Seeking Alpha

Cocrystal provides business update

  • Cocrystal Pharma (COCP) increases its cash position to $9.88M after raising $2.75M from eight investors including OPKO Health Chairman Philip Frost. Proceeds will be used to fund R&D and well as working capital.
  • IND for Hep C candidate expected to be filed by year end.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs